Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
about
Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cells.Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication.The prognostic value of phosphorylated Akt in breast cancer: a systematic review.Targeting the Akt/mTOR pathway in Brca1-deficient cancers.Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responsePhosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.Recurrent prognostic factors and expression of GLUT-1, PI3K and p-Akt in adenoid cystic carcinomas of the head and neck: Clinicopathological features and biomarkers of adenoid cystic carcinomaPrognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.Targeting the androgen receptor in triple-negative breast cancer.Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis.Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.The Androgen Receptor: Is It a Promising Target?Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics.Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer.Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.
P2860
Q30420138-C3E73D6D-D28B-4027-95AF-57811BD9F924Q34092016-18A835BC-27AC-47CA-ADFB-5CA335771900Q34925401-C0B82B2A-BA6A-47FF-B5C1-3E5BF0E62FCCQ35023287-F23B13E9-B7B8-4A80-80C8-45B27EFD8465Q35678658-790D7189-8F9C-4B1F-A871-C9799F7092C0Q35889638-FFF5BAC6-FA77-4476-8C6E-2EFE2D205B98Q36424369-1DFFFC6C-1058-48C1-B9F3-1BA0C2DCB922Q36447196-65686DD8-B492-4D3A-95B0-0C0D3CE713EBQ37174700-715BED5F-8FB6-4440-8FAE-0733C4E67AAEQ37497233-46DB6861-EA69-4E85-B402-7E0980837639Q38087850-9A5B2363-0702-4702-8CF3-84A438A7703AQ38907680-E986C771-627F-4942-8755-1E09523C7A1AQ38999707-72F802F3-7317-4D78-899E-F5ECDF26E38BQ41613206-E6EB7E63-C189-4398-A3C9-E9E6B6C7FB3BQ52339904-72A29A80-C1DD-4D4F-AC7D-604633771AD8Q52724909-29F5B50E-14D5-498A-8A07-627E31E7843BQ52726250-14CEF80A-C853-428A-AB1E-503A0ABC963DQ53130565-CF4EE821-E003-4B99-9F1B-C5F42A161F81Q54315683-15148E4C-2F0C-4856-AD97-63EFB7484963Q54339123-CC3E1162-F81D-4146-BC86-3007D4CB3253Q54518974-0C382448-FEFC-4CC5-9EE4-E057BF12FAF7
P2860
Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinicopathologic and molecula ...... early invasive breast cancer.
@en
Clinicopathologic and molecula ...... early invasive breast cancer.
@nl
type
label
Clinicopathologic and molecula ...... early invasive breast cancer.
@en
Clinicopathologic and molecula ...... early invasive breast cancer.
@nl
prefLabel
Clinicopathologic and molecula ...... early invasive breast cancer.
@en
Clinicopathologic and molecula ...... early invasive breast cancer.
@nl
P2860
P50
P1476
Clinicopathologic and molecula ...... early invasive breast cancer.
@en
P2093
Desmond G Powe
Mohamed A Ahmed
P2860
P2888
P304
P356
10.1007/S10549-010-1012-Y
P407
P577
2010-07-09T00:00:00Z